IDEXX Laboratories, Inc. (IDXX) Tops Q1 EPS by 2c; Increases FY11 EPS Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts IDXX Hot Sheet
Price: $560.38 -1.13%
EPS Growth %: +15.5%
Financial Fact:
Cost of service revenue: 97.67M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
EPS Growth %: +15.5%
Financial Fact:
Cost of service revenue: 97.67M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
IDEXX Laboratories, Inc. (NASDAQ: IDXX) reported Q1 EPS of $0.62, $0.02 better than the analyst estimate of $0.60. Revenue for the quarter came in at $292.7 million versus the consensus estimate of $285.61 million.
Increases FY11 EPS outlook from $2.62 - $2.68 to $2.66 - $2.71, versus the consensus of $2.66. Also sees FY11 revenue of $1.205 - $1.215 billion, versus the consensus of $1.19 billion.
Increases FY11 EPS outlook from $2.62 - $2.68 to $2.66 - $2.71, versus the consensus of $2.66. Also sees FY11 revenue of $1.205 - $1.215 billion, versus the consensus of $1.19 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boston Beer Co. (SAM) Tops Q3 EPS by 15c; offers guidance
- SLM (SLM) Misses Q3 EPS by 36c; lowers guidance
- Rithm Capital Corp. (RITM) Tops Q3 EPS by 6c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
